Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Navigator Medicines, Inc.

Clinical trials sponsored by Navigator Medicines, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New IV drug NAV-240 aims to calm painful skin bumps in hidradenitis suppurativa Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New IV drug NAV-240 aims to calm painful skin bumps in hidradenitis suppurativa

Disease control Recruiting now

This study tests whether NAV-240, given as an IV infusion, works better than a placebo for adults with moderate-to-severe hidradenitis suppurativa (HS). HS causes painful, inflamed bumps and tunnels under the skin. The main goal is to see if NAV-240 can reduce these bumps by at l…

Phase 2 • Sponsor: Navigator Medicines, Inc. • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC